NewLink Genetics in Ames held a ribbon cutting to mark the firm’s newly expanded facilities Wednesday.
The company, which was founded over 10 years ago by Dr. Charles Link, works to develop drugs to help fight cancer.
“NewLink Genetics is based on the idea that someday, instead of using traditional chemotherapy to fight cancer, you can actually stimulate the immune system to fight off cancer,” said Link.
The firm employs over 80 people in two buildings at the Iowa State University Research Park. The company has doubled it’ space at the Research Park from 25,000 square feet to 50,000.
Governor Terry Branstad attended the ribbon cutting and lauded NewLink Genetics for its effort to develop jobs.
“With NewLink Genetics on the cutting edge of this emerging cancer vaccine market, we think this can have a life-saving impact on millions of people throughout the world,” said Branstad.
Economic Partnership Director Debi Durham, and Ames Mayor Ann Campbell both shared personal stories of how cancer had touched their lives, during the ceremony.
The company is conducting some clinical trials of its products. If those tests are successful, the firm could be hiring a number of new employees.